$2,385,000
Income reported
8
Clients represented
49
Filings counted
0
Former members lobbying
Clients
8
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA $450,000
- BAVARIAN NORDIC INC. $420,000
- LONGHORN $360,000
- ALVOGEN $315,000
- PARTNER THERAPUTICS $300,000
- SEQIRUS $270,000
- FRESENIUS KABI $210,000
- GLAXOSMITHKLINE $60,000
Lobbyists named
2
- KELLY CHILDRESS LANGE
- ANDREW HAWKINS
Reported by year
2 years
- 2026 $970,000
- 2025 $1,415,000
Issues lobbied
3
Agencies and chambers lobbied
6
- Health & Human Services, Dept of (HHS)
- HOUSE OF REPRESENTATIVES
- SENATE
- White House Office
- Commerce, Dept of (DOC)
- U.S. Trade Representative (USTR)
Recent filings
54 total
Q3 amendment
View →
Q3 report
View →
Q3 reportNo activity
View →
Q3 terminationNo activity
View →
Q3 report
View →
Q3 terminationNo activity
View →
Q3 terminationNo activity
View →
Q3 terminationNo activity
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Q2 amendment
View →
Q2 report
View →
Q1 report
View →
Q1 report
View →
Q1 report
View →
Q1 report
View →
PARTNER THERAPUTICS
PARTNER THERAPUTICS
Amended
SEQIRUS
SEQIRUS
Amended
BAVARIAN NORDIC INC.
LONGHORN
ALVOGEN
FRESENIUS KABI
FRESENIUS KABI
PARTNER THERAPUTICS
LONGHORN
ALVOGEN
SEQIRUS
BAVARIAN NORDIC INC.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Amended
FRESENIUS KABI
PARTNER THERAPUTICS
LONGHORN
ALVOGEN